BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33894006)

  • 1. Real-world experience of off-label use of imiquimod 5% as an adjuvant therapy after surgery or as a monotherapy for lentigo maligna.
    Lallas A; Moscarella E; Kittler H; Longo C; Thomas L; Zalaudek I; Kyrgidis A; Manoli SM; di Meo N; Papageorgiou C; Apalla Z; Argenziano G
    Br J Dermatol; 2021 Sep; 185(3):675-677. PubMed ID: 33894006
    [No Abstract]   [Full Text] [Related]  

  • 2. Lentigo maligna successfully treated with imiquimod.
    du Plessis PJ
    S Afr J Surg; 2007 May; 45(2):72. PubMed ID: 17674567
    [No Abstract]   [Full Text] [Related]  

  • 3. Periocular lentigo maligna treated with imiquimod.
    O'Neill J; Ayers D; Kenealy J
    J Dermatolog Treat; 2011 Apr; 22(2):109-12. PubMed ID: 20666668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Reply to letter to the editor re: 'practical guide on the use of imiquimod cream to treat lentigo maligna'.
    Guitera P; Waddell A; Paton E; Fogarty GB; Hong A; Scolyer RA; Stretch JR; O'Donnell BA; Pellacani G
    Australas J Dermatol; 2022 May; 63(2):e198-e199. PubMed ID: 35107826
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to: A practical guide on the use of imiquimod cream to treat lentigo maligna.
    Muir J; McCormack C; De'Ambrosis B; Brown H; Kennedy D; Louie B; Smithers BM
    Australas J Dermatol; 2022 May; 63(2):e197-e198. PubMed ID: 35262178
    [No Abstract]   [Full Text] [Related]  

  • 6. [Imiquimod in the treatment of lentigo maligna].
    Nagore E; Botella-Estrada R
    Actas Dermosifiliogr; 2011 Oct; 102(8):559-62. PubMed ID: 21536245
    [No Abstract]   [Full Text] [Related]  

  • 7. Remission of extensive lentigo maligna after treatment with imiquimod.
    Piazza CD; Sampaio SA
    An Bras Dermatol; 2009; 84(1):82-4. PubMed ID: 19377765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rate of recurrence following treatment of lentigo maligna with carbon dioxide laser alone or in combination with imiquimod: Results of a long-term study.
    Kaur A; Javed MU; Venables B; Murison M; Yarrow J
    J Plast Reconstr Aesthet Surg; 2023 Oct; 85():95-97. PubMed ID: 37473646
    [No Abstract]   [Full Text] [Related]  

  • 9. Should topical imiquimod be used for positive margins in lentigo maligna?
    Wang TS; Griffiths CC; Roman EM
    J Am Acad Dermatol; 2021 Aug; 85(2):521-522. PubMed ID: 32387661
    [No Abstract]   [Full Text] [Related]  

  • 10. A novel two-stage treatment of lentigo maligna using ablative laser therapy followed by imiquimod.
    de Vries K; Rellum R; Habets JM; Prens EP
    Br J Dermatol; 2013 Jun; 168(6):1362-4. PubMed ID: 23252724
    [No Abstract]   [Full Text] [Related]  

  • 11. Topical Imiquimod for Management of Recurrent Lentigo Maligna Melanoma in Situ.
    Bartenjev MS; Isaković-Vidović S; Bartenjev I
    Acta Dermatovenerol Croat; 2020 Jul; 28(1):34-37. PubMed ID: 32650849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Topical imiquimod as palliative therapy for extensive lentigo maligna on the cheek].
    Cheikhrouhou H; Pouaha J; Claeys A; Truchetet F
    Ann Dermatol Venereol; 2010 Feb; 137(2):142-4. PubMed ID: 20171439
    [No Abstract]   [Full Text] [Related]  

  • 13. [How I treat ... lentigo maligna by topical imiquimod].
    Bourguignon R; Paquet P; Quatresooz P; Piérard GE
    Rev Med Liege; 2005 Sep; 60(9):691-4. PubMed ID: 16265961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of imiquimod 3.75% cream for the treatment of solar lentigo.
    Cantisani C; Cantoresi F; Mercuri SR; Binic I; Golubovic M; Marino R; Paolino G
    Dermatol Ther; 2020 Mar; 33(2):e13256. PubMed ID: 32031733
    [No Abstract]   [Full Text] [Related]  

  • 15. Imiquimod treatment of lentigo maligna: an open-label study of 34 primary lesions in 32 patients.
    Buettiker UV; Yawalkar NY; Braathen LR; Hunger RE
    Arch Dermatol; 2008 Jul; 144(7):943-5. PubMed ID: 18645150
    [No Abstract]   [Full Text] [Related]  

  • 16. Lentigo maligna treated with topical imiquimod: dermatoscopy usefulness in clinical monitoring.
    Costa MC; Abraham LS; Barcaui C
    An Bras Dermatol; 2011; 86(4):792-4. PubMed ID: 21987152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelanotic lentigo maligna managed with topical imiquimod as immunotherapy.
    Powell AM; Russell-Jones R
    J Am Acad Dermatol; 2004 May; 50(5):792-6. PubMed ID: 15097969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of dermoscopy to monitor clinical efficacy of imiquimod treatment for lentigo maligna.
    Micantonio T; Fargnoli MC; Peris K
    Arch Dermatol; 2006 Apr; 142(4):530-1. PubMed ID: 16618884
    [No Abstract]   [Full Text] [Related]  

  • 19. Imiquimod in the treatment of extensive recurrent lentigo maligna.
    Kamin A; Eigentler TK; Radny P; Bauer J; Weide B; Garbe C
    J Am Acad Dermatol; 2005 Feb; 52(2 Suppl 1):51-2. PubMed ID: 15692515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RECURRENT LENTIGO MALIGNA: CONSERVATIVE CONTINUOUS TREATMENT WITH IMIQUIMOD OR REPEATED SURGERY? A LONG-TERM FOLLOW-UP DERMOSCOPIC CASE STUDY.
    De Giorgi V; Zuccaro B; Silvestri F; Venturi F; Colombo J; Trane L
    Exp Oncol; 2023 Jun; 45(1):125-129. PubMed ID: 37417274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.